Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 6.48
0.621 %
$ 240 M
Market Cap
-11.57
P/E
Price Target
Average
0.31%
Revenue Forecast
Estimate
10.58%
EBIT
Estimate
--41.99%
Net Income
Estimate
--53.52%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Lifecore Biomedical, Inc.
Wall Street analysts predict an average 1-year price target for LFCR of $6.5 , with forecasts ranging from
a
low of
$5 to a high of $8 .
LFCR Lowest Price Target
Wall Street Target
5 USD
-22.84%
LFCR Average Price Target
Wall Street Target
6.5 USD
0.31%
LFCR Highest Price Target
Wall Street Target
8 USD
23.46%
REVENUE FORECAST
Revenue Forecast Chart LFCR
EBIT FORECAST
EBIT Forecast Chart LFCR
NET INCOME FORECAST
Net Income Chart LFCR